Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,768 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

Gene-Modified White Blood Cells Followed By Interleukin-2 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00085462

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

NCI - Surgery Branch Bethesda, Maryland, United States

View Trial Details

Completed

Monoclonal Antibody With or Without gp100 Peptides Plus Montanide ISA-51 in Treating Patients With Stage IV Melanoma

NCT00077532

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +10 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Effect of Topical Imiquimod on Lentigo Maligna

NCT01161888

Conditions: Hutchinson's Melanotic Freckle, Lentigo Maligna, Melanoma, +7 more
Locations: Dr J Marsden Queen Elizabeth Hospital, Birmingham, United Kingdom

View Trial Details

Completed

Vaccine Treatment in Combination With IL-2 and Treated Lymphocytes for Advanced Melanoma

NCT00080353

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: National Cancer Institute (NCI) Bethesda, Maryland, United States

View Trial Details

Completed

LMB-2 Immunotoxin and Vaccine Therapy in Treating Patients With Metastatic Melanoma That Cannot Be Removed By Surgery

NCT00295958

Conditions: Melanoma, Melanoma (Skin), Neoplasms, +11 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

NCI - Surgery Branch Bethesda, Maryland, United States

View Trial Details

Completed

Haploidentical NK Cell Infusion in Malignant Melanoma

NCT00846833

Conditions: Melanoma, Melanoma, Experimental, Neoplasms, +11 more
Locations: Seoul National University Hospital Seoul, South Korea

View Trial Details

Completed

A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma

NCT00281541

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Tuscon, Arizona, United States

Little Rock, Arkansas, United States

Aurora, Colorado, United States

Washington D.C., District of Columbia, United States

View Trial Details

Completed

Study of CP-675,206 in Refractory Melanoma

NCT00254579

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Research Site Scottsdale, Arizona, United States

Research Site Bentonville, Arkansas, United States

Research Site Fayetteville, Arkansas, United States

Research Site Little Rock, Arkansas, United States

View all 65 locations

View Trial Details

Completed

CP-675,206 In Patients With Advanced Melanoma

NCT00086489

Conditions: Malignant Melanoma, Melanoma, Neoplasms, +10 more
Locations: Research Site Los Angeles, California, United States

Research Site Tampa, Florida, United States

Research Site Chicago, Illinois, United States

Research Site Ann Arbor, Michigan, United States

View Trial Details

Completed

Study to Compare Two Formulations of CP-675,206 Monoclonal Antibody

NCT00431275

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Research Site Scottsdale, Arizona, United States

Research Site Aurora, Colorado, United States

Research Site Aventura, Florida, United States

Research Site Miami Beach, Florida, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions